Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells
Author:
Affiliation:
1. Department of Experimental Specialized Medical and Surgical and Odontostomatology Sciences; University of Messina; Messina; Italy
2. Department of Clinical and Experimental Medicine; University of Messina; Messina; Italy
Publisher
Wiley
Subject
Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12049/fullpdf
Reference49 articles.
1. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha;Adam;Mol. Cell. Biol.,2003
2. Anticancer activities of histone deacetylase inhibitors;Bolden;Nat. Rev. Drug Discov.,2006
3. Histone deacetylase inhibitors and malignant melanoma;Boyle;Pigment Cell Res.,2005
4. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin;Butler;Proc. Natl Acad. Sci. USA,2002
5. New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer;Cang;J Hematol Oncol.,2009
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine;Cell Death Discovery;2024-01-15
2. Butyrate Protects Barrier Integrity and Suppresses Immune Activation in a Caco-2/PBMC Co-Culture Model While HDAC Inhibition Mimics Butyrate in Restoring Cytokine-Induced Barrier Disruption;Nutrients;2023-06-15
3. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises;Pharmacology & Therapeutics;2022-12
4. Regulation of human T-cell leukemia virus type 1 antisense promoter by myocyte enhancer factor-2C in the context of adult T-cell leukemia and lymphoma;Haematologica;2022-05-26
5. Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma;International Journal of Molecular Sciences;2022-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3